- Home
- JZXN vs IMNN Comparison
JZXN vs IMNN Comparison
Compare JZXN & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- IMNN
- Stock Information
- Founded
- JZXN 2017
- IMNN 1982
- Country
- JZXN China
- IMNN United States
- Employees
- JZXN N/A
- IMNN N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- JZXN Consumer Discretionary
- IMNN Health Care
- Exchange
- JZXN Nasdaq
- IMNN Nasdaq
- Market Cap
- JZXN 15.3M
- IMNN 15.1M
- IPO Year
- JZXN 2021
- IMNN 1985
- Fundamental
- Price
- JZXN $1.42
- IMNN $1.02
- Analyst Decision
- JZXN
- IMNN Strong Buy
- Analyst Count
- JZXN 0
- IMNN 2
- Target Price
- JZXN N/A
- IMNN $21.50
- AVG Volume (30 Days)
- JZXN 45.8K
- IMNN 244.7K
- Earning Date
- JZXN 10-15-2024
- IMNN 11-12-2024
- Dividend Yield
- JZXN N/A
- IMNN N/A
- EPS Growth
- JZXN N/A
- IMNN N/A
- EPS
- JZXN N/A
- IMNN N/A
- Revenue
- JZXN $7,597,423.00
- IMNN N/A
- Revenue This Year
- JZXN N/A
- IMNN N/A
- Revenue Next Year
- JZXN N/A
- IMNN N/A
- P/E Ratio
- JZXN N/A
- IMNN N/A
- Revenue Growth
- JZXN 81.94
- IMNN N/A
- 52 Week Low
- JZXN $1.00
- IMNN $0.48
- 52 Week High
- JZXN $67.60
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- JZXN 42.91
- IMNN 45.13
- Support Level
- JZXN $1.36
- IMNN $0.99
- Resistance Level
- JZXN $1.76
- IMNN $1.08
- Average True Range (ATR)
- JZXN 0.17
- IMNN 0.05
- MACD
- JZXN 0.01
- IMNN 0.00
- Stochastic Oscillator
- JZXN 11.13
- IMNN 50.00
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its business segments are sales of NEVs and Franchisees services. The company generates a majority of its revenue from the NEVs segment. Geographically, the firm operates in China.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.